Residual renal function in hemodialysis patients may protect against hyperaluminemia

Kidney Int. 1987 Nov;32(5):710-3. doi: 10.1038/ki.1987.264.

Abstract

We investigated 106 home hemodialysis patients whose mean [+/- SEM] serum aluminum (Al) concentration was 60.9 +/- 4.1 micrograms/liter. Serum Al concentration was inversely related to daily urine output (r = -0.52, P less than 0.001). Urine volume and measurements of Al exposure were included in a multivariate analysis of serum Al concentration in the 62 patients whose urine output was greater than 10 ml/day. The multiple correlation coefficient (r) was 0.70 (P less than 0.001) and the percentage contributions to r2 (indicating the relative importance of each factor) were: urine output 57%, oral Al intake 36%, total dialysis hours 7%. The additional contribution from cumulative water Al was negligible. In a subgroup of 26 patients with a urine output exceeding 10 ml/day, urinary Al excretion averaged 15.4 micrograms/day, and renal Al clearance and serum Al concentration were inversely related (r = -0.69, P less than 0.001). We conclude that Al-containing phosphate binders were a more important source of Al than was dialysate in these patients and that residual renal function can reduce the severity of hyperaluminemia in hemodialysis patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aluminum / blood*
  • Creatinine / blood
  • Female
  • Glomerular Filtration Rate
  • Hemodialysis, Home*
  • Humans
  • Kidney Failure, Chronic / blood*
  • Kidney Function Tests*
  • Male
  • Middle Aged
  • Urodynamics

Substances

  • Creatinine
  • Aluminum